BGM Group names Zhanchang Xin chairman after Chen Xin resigns

PUBT · 1d ago
BGM Group names Zhanchang Xin chairman after Chen Xin resigns
  • Chairman and Co-CEO Chen Xin resigned effective July 30, 2026 for personal reasons.
  • Zhanchang Xin named chairman effective July 30, 2026; has led Gansu Qilianshan Pharmaceutical since 2006 with 35+ years in pharma R&D.
  • Hong Li appointed co-CEO effective July 30, 2026; CFO of Gansu Qilianshan Pharmaceutical since 2008 with a finance and accounting background.
  • Zhanchang Xin is Chen Xin’s father.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BGM Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-088690), on July 30, 2026, and is solely responsible for the information contained therein.